Growth Engines Medtronic is focusing on ablation, robotics, and hypertension therapies as key growth drivers; opportunities to cross-sell across these lines, supply complementary devices, disposables, and integrated software; target hospitals adopting multi-modality procedures; emphasize value-based outcomes and cost per case.

Robotics Momentum Hugo platform gains traction with urologic approvals; competitive landscape includes Intuitive Surgical; opportunities to win more share via expanded procedures, training services, seamless OR integration, and packaging with imaging, navigation, and data analytics; approach with ROI case studies.

Financial Stability Strong credit rating and dividend aristocrat status supports long-term procurement commitments; education on total-cost-of-ownership and service-based pricing can ease budget cycles; despite near-term tariff and FX pressures, growth guidance suggests steady demand for core therapies; pitch multi-year service contracts and integrated care solutions.

Tech Security Tailored offerings around cloud-enabled device data, AI-enabled outcomes analytics, and cybersecurity for connected devices align with Medtronic's AWS, Salesforce, and security stack; propose data platform partnerships and compliant deployment models; emphasize security and regulatory compliance as a differentiator.

Market Access Leverage existing global sales infrastructure including Salesforce; identify cross-sell opportunities across hospital networks, IDNs, and international markets; propose bundled procurement, training programs, and digital ordering to improve adoption rates and shorten sales cycles.